145 related articles for article (PubMed ID: 35319783)
1. Poorer survival outcomes in patients with multiple versus single primary melanoma.
Karapetyan L; Yang X; Knight AD; Huang Z; Wang H; Sander CA; Minnier CP; Wilson M; Li A; Karunamurthy A; Storkus WJ; Kirkwood JM
Cancer; 2022 Jun; 128(11):2098-2106. PubMed ID: 35319783
[TBL] [Abstract][Full Text] [Related]
2. Outcomes and Risk Factors in Patients with Multiple Primary Melanomas.
Nosrati A; Yu WY; McGuire J; Griffin A; de Souza JR; Singh R; Linos E; Chren MM; Grimes B; Jewell NP; Wei ML
J Invest Dermatol; 2019 Jan; 139(1):195-201. PubMed ID: 30031745
[TBL] [Abstract][Full Text] [Related]
3. Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma.
Weiss SA; Han SW; Lui K; Tchack J; Shapiro R; Berman R; Zhong J; Krogsgaard M; Osman I; Darvishian F
Hum Pathol; 2016 Nov; 57():116-125. PubMed ID: 27473267
[TBL] [Abstract][Full Text] [Related]
4. Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011.
Moore MM; Geller AC; Warton EM; Schwalbe J; Asgari MM
J Am Acad Dermatol; 2015 Oct; 73(4):630-6. PubMed ID: 26298295
[TBL] [Abstract][Full Text] [Related]
5. Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma.
El Sharouni MA; Aivazian K; Witkamp AJ; Sigurdsson V; van Gils CH; Scolyer RA; Thompson JF; van Diest PJ; Lo SN
JAMA Dermatol; 2021 Feb; 157(2):166-173. PubMed ID: 33355600
[TBL] [Abstract][Full Text] [Related]
6. Optimization of an automated tumor-infiltrating lymphocyte algorithm for improved prognostication in primary melanoma.
Chou M; Illa-Bochaca I; Minxi B; Darvishian F; Johannet P; Moran U; Shapiro RL; Berman RS; Osman I; Jour G; Zhong H
Mod Pathol; 2021 Mar; 34(3):562-571. PubMed ID: 33005020
[TBL] [Abstract][Full Text] [Related]
7. A Novel Numerical Scoring System for Melanoma Tumor-infiltrating Lymphocytes Has Better Prognostic Value Than Standard Scoring.
Saldanha G; Flatman K; Teo KW; Bamford M
Am J Surg Pathol; 2017 Jul; 41(7):906-914. PubMed ID: 28368925
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of tumor-infiltrating lymphocytes are associated with improved recurrence-free survival in stage 1A non-small-cell lung cancer.
Horne ZD; Jack R; Gray ZT; Siegfried JM; Wilson DO; Yousem SA; Nason KS; Landreneau RJ; Luketich JD; Schuchert MJ
J Surg Res; 2011 Nov; 171(1):1-5. PubMed ID: 21571304
[TBL] [Abstract][Full Text] [Related]
9. Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study.
Thomas NE; Busam KJ; From L; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Groben PA; Hao H; Orlow I; Reiner AS; Luo L; Paine S; Ollila DW; Wilcox H; Begg CB; Berwick M
J Clin Oncol; 2013 Nov; 31(33):4252-9. PubMed ID: 24127443
[TBL] [Abstract][Full Text] [Related]
10. Survival for patients with single and multiple primary melanomas: the genes, environment, and melanoma study.
Kricker A; Armstrong BK; Goumas C; Thomas NE; From L; Busam K; Kanetsky PA; Gallagher RP; Marrett LD; Groben PA; Gruber SB; Anton-Culver H; Rosso S; Dwyer T; Berwick M;
JAMA Dermatol; 2013 Aug; 149(8):921-7. PubMed ID: 23784017
[TBL] [Abstract][Full Text] [Related]
11. Histological regression in melanoma: impact on sentinel lymph node status and survival.
Aivazian K; Ahmed T; El Sharouni MA; Stretch JR; Saw RPM; Spillane AJ; Shannon KF; Ch'ng S; Nieweg OE; Thompson JF; Lo SN; Scolyer RA
Mod Pathol; 2021 Nov; 34(11):1999-2008. PubMed ID: 34247192
[TBL] [Abstract][Full Text] [Related]
12. Deep learning-based scoring of tumour-infiltrating lymphocytes is prognostic in primary melanoma and predictive to PD-1 checkpoint inhibition in melanoma metastases.
Chatziioannou E; Roßner J; Aung TN; Rimm DL; Niessner H; Keim U; Serna-Higuita LM; Bonzheim I; Kuhn Cuellar L; Westphal D; Steininger J; Meier F; Pop OT; Forchhammer S; Flatz L; Eigentler T; Garbe C; Röcken M; Amaral T; Sinnberg T
EBioMedicine; 2023 Jul; 93():104644. PubMed ID: 37295047
[TBL] [Abstract][Full Text] [Related]
13. Assessing the Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Melanoma Using Pathologic Features Identified by Natural Language Processing.
Yang J; Lian JW; Chin YH; Wang L; Lian A; Murphy GF; Zhou L
JAMA Netw Open; 2021 Sep; 4(9):e2126337. PubMed ID: 34550383
[TBL] [Abstract][Full Text] [Related]
14. Immune biomarkers are more accurate in prediction of survival in ulcerated than in non-ulcerated primary melanomas.
de Moll EH; Fu Y; Qian Y; Perkins SH; Wieder S; Gnjatic S; Remark R; Bernardo SG; Moskalenko M; Yao J; Ferringer T; Chang R; Chipuk J; Horst BA; Birge MB; Phelps RG; Saenger YM
Cancer Immunol Immunother; 2015 Sep; 64(9):1193-203. PubMed ID: 26076664
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of Tumor-Infiltrating Lymphocyte Grade in Melanoma: A Meta-Analysis.
Sun Q; Sun H; Wu N; Cong L; Cong X
Dermatology; 2020; 236(6):481-492. PubMed ID: 32023619
[TBL] [Abstract][Full Text] [Related]
16. Multiple primary melanomas versus single melanoma of the head and neck: a comparison of genetic, diagnostic, and therapeutic implications.
Pollio A; Tomasi A; Pellacani G; Ruini C; Mandel VD; Fortuna G; Seidenari S; Ponti G
Melanoma Res; 2014 Jun; 24(3):267-72. PubMed ID: 24638154
[TBL] [Abstract][Full Text] [Related]
17. Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy.
Luen SJ; Salgado R; Dieci MV; Vingiani A; Curigliano G; Gould RE; Castaneda C; D'Alfonso T; Sanchez J; Cheng E; Andreopoulou E; Castillo M; Adams S; Demaria S; Symmans WF; Michiels S; Loi S
Ann Oncol; 2019 Feb; 30(2):236-242. PubMed ID: 30590484
[TBL] [Abstract][Full Text] [Related]
18. Distribution pattern of tumor infiltrating lymphocytes and tumor microenvironment composition as prognostic indicators in anorectal malignant melanoma.
Kim SW; Kim YI; Mustafa B; Kim MJ; Jeong G; Ahn SM; Lim SB; Yu CS; Kim JC; Hong SM; Park IJ
Mod Pathol; 2021 Jan; 34(1):141-160. PubMed ID: 32709987
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of regression and tumor infiltrating lymphocytes is associated with more favorable survival in melanoma.
Tas F; Erturk K
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2721-2729. PubMed ID: 33611652
[TBL] [Abstract][Full Text] [Related]
20. Local immune response predicts survival in patients with thick (t4) melanomas.
Cintolo JA; Gimotty P; Blair A; Guerry D; Elder DE; Hammond R; Elenitsas R; Xu X; Fraker D; Schuchter LM; Czerniecki BJ; Karakousis G
Ann Surg Oncol; 2013 Oct; 20(11):3610-7. PubMed ID: 23838911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]